-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 FAH5Ze6aKF+A6Rh++abUFL70Jr5BD0fx1dI0vI9sbwjn/OvTZdij8GKchp4VbMUx
 IwpRRK6Q+GNpme/bQa3MCg==

<SEC-DOCUMENT>0000950137-06-007967.txt : 20060721
<SEC-HEADER>0000950137-06-007967.hdr.sgml : 20060721
<ACCEPTANCE-DATETIME>20060721141908
ACCESSION NUMBER:		0000950137-06-007967
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20060720
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20060721
DATE AS OF CHANGE:		20060721

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NANOPHASE TECHNOLOGIES CORPORATION
		CENTRAL INDEX KEY:			0000883107
		STANDARD INDUSTRIAL CLASSIFICATION:	MISCELLANEOUS PRIMARY METAL PRODUCTS [3390]
		IRS NUMBER:				363687863
		STATE OF INCORPORATION:			IL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-22333
		FILM NUMBER:		06973866

	BUSINESS ADDRESS:	
		STREET 1:		453 COMMERCE ST
		CITY:			BURR RIDGE
		STATE:			IL
		ZIP:			60521
		BUSINESS PHONE:		6303231200

	MAIL ADDRESS:	
		STREET 1:		453 COMMERCE STREET
		CITY:			BURR RIDGE
		STATE:			IL
		ZIP:			60521
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>c06981e8vk.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<HTML>
<HEAD>
<TITLE>e8vk</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 1pt solid black; font-size: 1pt">&nbsp;</DIV>






<DIV align="center" style="font-size: 14pt; margin-top: 12pt"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION</B>
</DIV>

<DIV align="center" style="font-size: 12pt"><B>Washington D.C., 20549</B>
</DIV>

<DIV align="center" style="font-size: 18pt; margin-top: 12pt"><B>Form&nbsp;8-K</B>
</DIV>


<DIV align="center" style="font-size: 12pt; margin-top: 12pt"><B>Current Report<BR>
Pursuant to Section&nbsp;13 or 15(d) of the Securities Exchange Act of 1934</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">Date Of Report (Date Of Earliest Event Reported): July&nbsp;20, 2006
</DIV>

<DIV align="center" style="font-size: 24pt; margin-top: 12pt"><B>NANOPHASE TECHNOLOGIES CORPORATION</B>
</DIV>

<DIV align="center" style="font-size: 10pt">(Exact Name of Registrant as Specified in its Charter)</DIV>



<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Commission File Number: 0-22333</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="47%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top"><B>Delaware</B><BR>
(State or Other Jurisdiction of<BR>
Incorporation or Organization)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>36-3687863</B><BR>
(I.R.S. Employer<BR>
Identification No.)</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>1319 Marquette Drive, Romeoville, Illinois 60446</B><BR>
(Address of Principal Executive Offices, Including Zip Code)
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>(630)&nbsp;771-6700</B><BR>
(Registrant&#146;s Telephone Number, Including Area Code)
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 30pt">(Former name or former address, if changed since last report)
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 18pt">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy
the filing obligation of the registrant under any of the following provisions:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><FONT style="font-family: Wingdings">&#168;</FONT> Written communications pursuant to Rule&nbsp;425 under the Securities Act (17 CFR 230.425)
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><FONT style="font-family: Wingdings">&#168;</FONT> Soliciting material pursuant to Rule&nbsp;14a-12 under the Exchange Act (17 CFR 240.14a-12)
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><FONT style="font-family: Wingdings">&#168;</FONT> Pre-commencement communications pursuant to Rule&nbsp;14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><FONT style="font-family: Wingdings">&#168;</FONT> Pre-commencement communications pursuant to Rule&nbsp;13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
</DIV>


<DIV style="width: 100%; border-bottom: 1pt solid black; margin-top: 10pt; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>





<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">








<DIV align="center" style="font-size: 10pt; margin-top: 18pt">Items to be Included in this Report
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;2.02. Results of Operations and Financial Condition</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">On July&nbsp;20, 2006, the Corporation issued a press release announcing financial results for the
quarterly fiscal period ended June&nbsp;30, 2006. A copy of the press release is being furnished as
Exhibit&nbsp;99.1 to this Form 8-K.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;9.01. Financial Statements and Exhibits</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Exhibit&nbsp;99.1 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Press Release dated July&nbsp;20, 2006

</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Signature(s)</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the Requirements of the Securities Exchange Act of 1934, the Registrant has duly
caused this Report to be signed on its behalf by the Undersigned hereunto duly authorized.
</DIV>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">Nanophase Technologies Corporation<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">Date: July 21, 2006&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ JOSEPH CROSS
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">JOSEPH CROSS     &nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">Chief Executive Officer&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>


<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>c06981exv99w1.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<HTML>
<HEAD>
<TITLE>exv99w1</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">





<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Exhibit&nbsp;99.1
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">Nanophase Announces Second Quarter 2006 Revenue<BR>
Thursday July&nbsp;20, 5:16 pm ET<BR>
Achieves Highest Quarterly Revenue in Company History
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">ROMEOVILLE, Ill., July&nbsp;20 /PRNewswire-FirstCall/ &#151; Nanophase Technologies (Nasdaq: <U>NANX</U> -
<U>News</U>), a technology leader in nanomaterials and advanced nanoengineered products, announced
that second quarter 2006 revenue was approximately $2.4&nbsp;million (unaudited), representing the
highest quarterly revenue in the Company&#146;s history. Nanophase&#146;s revenues for the first half of 2006
were approximately $4.4&nbsp;million (unaudited)&nbsp;representing an approximate 20% increase over the first
half of 2005.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&#147;Nanophase had a strong second quarter and first half revenue growth and made significant progress
in many operational and new market initiatives,&#148; stated Joseph Cross, Nanophase&#146;s president and
CEO. &#147;We continue to expect that 2006 revenue will be materially stronger in the second half of
2006 than it was in the second half of 2005. We base these expectations on growth in architectural
and industrial coatings predicated on customer forecasts and orders received. We have recently
completed the installation of the new NanoArc&#153; reactor and volume dispersion facilities that
were financed by the $1.6&nbsp;million loan from BYK Chemie, a company of Altana Chemie, and expect to
see increasing revenue from the industrial coatings market. As we discussed in last quarter&#146;s
conference call, we have added a significant customer in architectural coatings and already are
achieving volume deliveries beginning this second quarter with anticipated increases in the second
half of 2006. We also plan to continue introducing new nanomaterials targeted for antimicrobial,
catalysts, and coatings applications where we are seeing market pull. We remain positive on revenue
growth for the second half of 2006 and 2007.&#148;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Nanophase plans to release earnings for the second quarter of 2006 on July&nbsp;27 at approximately 3:00
PM CDT, 4:00 PM EDT. Nanophase has scheduled its quarterly conference call for July&nbsp;27 at 4:00 PM
CDT, 5:00 PM EDT, which will be hosted by Joseph Cross, president and CEO, and Jess Jankowski, CFO.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The call may be accessed through the Company&#146;s website, <U>http://www.nanophase.com</U> , and
clicking on the link under Investor Relations and Calendar of Events. If you are unable to attend,
a replay will be available through August&nbsp;3, 2006 by dialing 706-645-9291 and entering code
2695662, or by logging onto the Company&#146;s website and following the above directions.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Nanophase Technologies Corporation (NANX), <U>http://www.nanophase.com</U> , is a leader in
nanomaterials technologies and provides nanoengineered solutions for multiple industrial product
applications. Using a platform of patented and proprietary integrated nanomaterial technologies,
the Company creates products with unique performance attributes from two ISO 9001:2000 and ISO
14001 facilities. Nanophase delivers commercial quantity and quality nanoparticles, coated
nanoparticles, and nanoparticle dispersions in a variety of media. The Company owns or licenses 18
United States and 43 foreign patents and patent applications. Information about Nanophase may be
found in the Company&#146;s public filings or on its website.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">This press release contains words such as &#147;expects&#148;, &#147;shall&#148;, &#147;will&#148;, &#147;believes&#148; and similar
expressions that are intended to identify forward- looking statements within the meaning of the
Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. Such statements in
this announcement are made based on the Company&#146;s current beliefs, known events and circumstances
at the time of publication, and as such, are subject in the future to unforeseen risks and
uncertainties that could cause the Company&#146;s results of operations, performance and achievements to
differ materially from current expectations expressed in, or implied by, these forward-looking
statements. These risk and uncertainties include the following: a decision by a customer to cancel
a purchase order or supply agreement in light of the Company&#146;s dependence on a limited number of
key customers; uncertain demand for, and acceptance of, the Company&#146;s nanocrystalline materials;
the Company&#146;s manufacturing capacity and product mix flexibility in light of customer demand; the
Company&#146;s limited marketing experience; changes in development and distribution relationships; the
impact of competitive products and technologies; the Company&#146;s dependence on patents and protection
of proprietary information; the
resolution of litigation in which the Company may become involved; and other risks described in the
Company&#146;s Form&nbsp;10Q filed May&nbsp;9, 2006 and other filings with the Securities and Exchange Commission.
In addition, the Company&#146;s forward-looking statements could be affected by general industry and
market conditions and growth rates. Except as required by federal securities laws, the Company
undertakes no obligation to update or revise these forward-looking statements to reflect new
events, uncertainties or other contingencies.
</DIV>


<P align="center" style="font-size: 10pt">
</DIV>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
